Scott Chappell focuses his practice on helping clients best achieve their business goals. His practice includes drafting patent applications and prosecuting patent claims – domestically and internationally, for both large corporations and startup companies. Scott has experience with a range of technologies, from pharmaceuticals and medical devices to consumer products.
Prior to joining Bookoff McAndrews, Scott was a law clerk at a leading intellectual property firm in New York City and worked in-house at a multinational pharmaceutical company. In law school, he served as an editor on Suffolk’s Journal of High Technology Law, as member of the Patent Law Moot Court Team, and as a teaching assistant for legal writing classes. Scott also volunteered for the New England Innocence Project, providing pro bono legal representation to people who have claims of wrongful conviction.
While pursuing his undergraduate degree, Scott worked with high-throughput screening technology to study genetic factors in stem cell differentiation at Boston University’s School of Medicine.
- Worked on a team that managed a large international patent portfolio related to a drug targeting the central nervous system for a Fortune 300 pharmaceutical company.
- Advised a startup company developing a nanotechnology-based drug delivery platform on patent portfolio strategy.
- Northeast regional champion, Irving Marcus Award winner and national finalist of the 41th Annual Giles Sutherland Rich Intellectual Property Moot Court Competition, and received award for submitting the best appellate brief.
- During law school, interned at the Charles Stark Draper Laboratory and worked on intellectual property license agreements and freedom-to-operate analyses.
- District of Columbia
- U.S. Patent and Trademark Office
- Suffolk University Law School, J.D., Intellectual Property Law Concentration with Patent Law Specialization, with distinction, May 2015
- Boston University, B.S., Biomedical Engineering, May 2010
- Author. “Federal Circuit Finds Relative Term Definite,” BoMc Blog, April 4, 2018.
- Author. “Federal Circuit Shines Light On ‘Broadest Reasonable Interpretation‘,” BoMc Blog, August 14, 2017.
- Coauthor. “A Novel Library Screen Identifies Immunosuppressors That Promote Osteoblast Differentiation,” Bone. 2012 June; 50(6):1294-303.
- Massachusetts Bar Association (MBA), Member